A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology
Early-Onset Schizophrenia (EOS) is a very rare mental disorder that is a form of schizophrenia occurring before the age of 18. EOS is a brain disease marked by an early onset of positive and negative symptoms of psychosis that impact development and cognitive functioning. Clinical manifestations com...
Main Authors: | Malgorzata Marta Drozd, Maria Capovilla, Carlo Previderé, Mauro Grossi, Florence Askenazy, Barbara Bardoni, Arnaud Fernandez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.792218/full |
Similar Items
-
Childhood-Onset Schizophrenia: A Systematic Overview of Its Genetic Heterogeneity From Classical Studies to the Genomic Era
by: Arnaud Fernandez, et al.
Published: (2019-12-01) -
Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol
by: Kaleeckal G. Harikumar, et al.
Published: (2021-12-01) -
Cadherin‐11 increases tumor cell proliferation and metastatic potential via Wnt pathway activation
by: Yayu Liu, et al.
Published: (2023-10-01) -
Structure and Tissue Distribution of Cholecystokinin-1 Receptor in Chicken
by: Takeshi Ohkubo, et al.
Published: (2007-01-01) -
Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics
by: Laurence J. Miller, et al.
Published: (2021-06-01)